CONCLUSIONS: Olmesartan monotherapy showed robust reduction of urinary protein in normotensive IgA nephropathy patients, suggesting that this effect is independent of its blood pressure-lowering properties.
PMID: 19384840 [PubMed - in process] (Source: Journal of Nephrology)